Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

Thioguanine Inhibitors

Thioguanine, a purine analog, plays a pivotal role in nucleic acid metabolism, serving as a substrate mimic that integrates into DNA and RNA. This integration disrupts various cellular processes, primarily nucleic acid synthesis and repair. The core function of thioguanine within cellular biochemistry lies in its ability to closely resemble the natural purine bases, thereby interfering with the enzymatic activities that facilitate nucleotide biosynthesis and the replication machinery. By inserting itself in place of the natural bases during the DNA/RNA synthesis phase, thioguanine induces errors in the nucleic acid sequences, leading to malfunctioning proteins or triggering apoptosis due to irreparable genetic damage. This mechanism underscores a fundamental aspect of cellular regulation, where the fidelity of genetic information transmission is paramount.

The inhibition mechanism of thioguanine hinges on its structural similarity to natural nucleotides, enabling it to be unwittingly utilized by nucleotide synthesis enzymes and DNA polymerases. Once incorporated into DNA or RNA, thioguanine precipitates a cascade of errors in the genetic code, effectively halting cell division and leading to cell death. Furthermore, its incorporation affects the action of repair enzymes tasked with correcting DNA errors, leading to an accumulation of genetic mutations. This process illustrates the delicate balance within cellular systems between proliferation and maintenance of genomic integrity. Inhibition by thioguanine showcases the intricate interplay between enzymatic specificity and substrate mimicry, a testament to the sophisticated regulatory mechanisms that govern cellular homeostasis and the vulnerabilities within these systems that can be exploited to disrupt pathological cellular proliferation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Allopurinol

315-30-0sc-207272
25 g
$128.00
(0)

Inhibits xanthine oxidase, which could decrease the breakdown of thioguanine, altering its intended effects.

Febuxostat

144060-53-7sc-207680
10 mg
$168.00
3
(1)

Another xanthine oxidase inhibitor that could lead to altered thioguanine activity by similar means as allopurinol.

6-Mercaptopurine

50-44-2sc-361087
sc-361087A
50 mg
100 mg
$71.00
$102.00
(0)

Competes with thioguanine for HGPRT, potentially inhibiting the activation of thioguanine.

Azathioprine

446-86-6sc-210853D
sc-210853
sc-210853A
sc-210853B
sc-210853C
500 mg
1 g
2 g
5 g
10 g
$199.00
$173.00
$342.00
$495.00
$690.00
1
(1)

Prodrug of 6-mercaptopurine; could also compete with thioguanine for activation by HGPRT.

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$92.00
$209.00
33
(5)

Inhibits dihydrofolate reductase, leading to reduced purine synthesis and potential alterations in thioguanine metabolism.

Sulfasalazine

599-79-1sc-204312
sc-204312A
sc-204312B
sc-204312C
1 g
2.5 g
5 g
10 g
$60.00
$75.00
$125.00
$205.00
8
(1)

Inhibits TPMT, which may increase the levels of active thioguanine at the risk of toxicity.

Fluorouracil

51-21-8sc-29060
sc-29060A
1 g
5 g
$36.00
$149.00
11
(1)

Affects nucleotide synthesis and could interfere with the metabolic pathway of thioguanine.

Ketoconazole

65277-42-1sc-200496
sc-200496A
50 mg
500 mg
$62.00
$260.00
21
(1)

Inhibits CYP enzymes, which might alter the metabolism of thioguanine.